Evidence map›Paper›PMID 32059806›Full record

ArticleCell stem cell2020

Embryonic Barcoding of Equipotent Mammary Progenitors Functionally Identifies Breast Cancer Drivers.

Zhe Ying, Slobodan Beronja

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. In vivo functional screens revealScience advances · 2025
    Article
  8. Review
  9. The molecular chronology of mammary epithelial cell fate switching.bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Cellular Organization of the Mammary Gland: Insights From Microscopy.Journal of mammary gland biology and neoplasia · 2021
    Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhe YingDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Slobodan BeronjaDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Electronic address: beronja@fredhutch.org.
Fred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasisR01AR070780 · NIAMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Slobodan Beronja · 2017 to 2026
$4.2M
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancerR00DE029229 · NIDCR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YING, ZHE · 2021 to 2023
$744k
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancerK99DE029229 · NIDCR · FRED HUTCHINSON CANCER RESEARCH CENTER · PI YING, ZHE · 2019 to 2020
$325k
NCI NIH HHS P30 CA015704NIAMS NIH HHS R01 AR070780NIDCR NIH HHS K99 DE029229NIDCR NIH HHS R00 DE029229
6 · The paper itself

Abstract

Identification of clinically relevant drivers of breast cancers in intact mammary epithelium is critical for understanding tumorigenesis yet has proven challenging. Here, we show that intra-amniotic lentiviral injection can efficiently transduce progenitor cells of the adult mammary gland and use that as a platform to functionally screen over 500 genetic lesions for functional roles in tumor formation. Targeted progenitors establish long-term clones of both luminal and myoepithelial lineages in adult animals, and via lineage tracing with stable barcodes, we found that each mouse mammary gland is generated from a defined number of ∼120 early progenitor cells that expand uniformly with equal growth potential. We then designed an in vivo screen to test genetic interactions in breast cancer and identified candidates that drove not only tumor formation but also molecular subtypes. Thus, this methodology enables rapid and high-throughput cancer driver discovery in mammary epithelium.

Indexed as

Mammary Glands, AnimalNeoplasmsAnimalsCell DifferentiationCell LineageCells, CulturedEpithelial CellsMiceStem Cellsbarcoded lentivirusbreast cancer driverectodermal mammary progenitorin-utero injectionin vivo screenpatient derived lesionquantitative lineage tracing

Identifiers

PMID32059806
PMCPMC7104873
OpenAlexW3006158503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.